SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
S-8	Jan 19, 2024	FORM S-8
8-K	Jan 8, 2024	FORM 8-K
424B5	Jan 5, 2024	424B5
424B5	Jan 4, 2024	424B5
8-K	Jan 3, 2024	FORM 8-K
8-K	Dec 22, 2023	FORM 8-K
8-K	Dec 13, 2023	FORM 8-K
4	Dec 8, 2023	OWNERSHIP DOCUMENT
4	Dec 8, 2023	OWNERSHIP DOCUMENT
4	Dec 8, 2023	OWNERSHIP DOCUMENT
4	Dec 8, 2023	OWNERSHIP DOCUMENT
8-K	Dec 8, 2023	FORM 8-K
8-K	Nov 9, 2023	8-K
10-Q	Nov 9, 2023	10-Q
424B5	Nov 1, 2023	424B5
8-K	Oct 31, 2023	FORM 8-K
8-K	Oct 16, 2023	FORM 8-K
8-K	Oct 13, 2023	FORM 8-K
8-K	Aug 10, 2023	8-K
10-Q	Aug 10, 2023	10-Q
8-K	Jun 21, 2023	FORM 8-K
8-K	Jun 1, 2023	FORM 8-K
8-K	May 11, 2023	8-K
10-Q	May 11, 2023	10-Q
ARS	Apr 28, 2023	ARS

← Newer Page 6 of 51 · 1272 filings Older →